Exome array analysis identifies a common Variant in IL27 associated with chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 194, Issue 1, 2016, Pages 48-57

  Hobbs, Brian D ^a,b   Parker, Margaret M ^a   Chen, Han ^c   Lao, Taotao ^a   Hardin, Megan ^a,b   Qiao, Dandi ^a   Hawrylkiewicz, Iwona ^d   Sliwinski, Pawel ^d   Yim, Jae Joon ^e   Kim, Woo Jin ^f   Kim, Deog Kyeom ^g   Castaldi, Peter J ^a,h   Hersh, Craig P ^a,b   Morrow, Jarrett ^a   Celli, Bartolome R ^b   Pinto Plata, Victor M ⁱ   Criner, Gerald J ^b   Marchetti, Nathaniel ^j   Bueno, Raphael ^k   Agusti, Alvar ^l   Make, Barry J ^m   Crapo, James D ⁿ   Calverley, Peter M ^o   Donner, Claudio F ^p   Lomas, David A ^q   Wouters, Emiel F M ^r   Vestbo, Jorgen ^s   Pare, Peter D ^t   Levy, Robert D ^t   Rennard, Stephen I ^u   Zhou, Xiaobo ^a   Laird, Nan M ^e   Lin, Xihong ^c   Beaty, Terri H ^v   Silverman, Edwin K ^a,b   Cho, Michael H ^a,b   more..

^a CHANNING LABORATORY   (United States)

^b Division of Pulmonary and Critical Care Medicine   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d Institute for Tuberculosis and Lung Diseases   (Poland)

^e Seoul National University College of Medicine   (South Korea)

^f Kangwon National University   (South Korea)

^g Seoul National University Boramae Hospital   (South Korea)

^h Division of General Medicine and Primary Care   (United States)

ⁱ BAYSTATE MEDICAL CENTER   (United States)

^j TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k BRIGHAM AND WOMEN S HOSPITAL   (United States)

^l UNIVERSITY OF BARCELONA   (Spain)

^m DEPARTMENT OF MEDICINE   (United States)

ⁿ UNIVERSITY OF LIVERPOOL   (United Kingdom)

^o Multidisciplinary and Rehabilitation Outpatient Clinic   (Italy)

^p UNIVERSITY COLLEGE LONDON   (United Kingdom)

^q MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^r UNIVERSITY OF MANCHESTER   (United Kingdom)

^s UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^t UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^u ASTRAZENECA   (United Kingdom)

^v JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

Chronic Obstructive Pulmonary Disease; Exome; Genetics; IL 27

Indexed keywords

AGER PROTEIN; INTERLEUKIN 27; NICOTINE; PROTEIN; SERINE PROTEINASE INHIBITOR; SERPINA1 PROTEIN; STROMELYSIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXOME; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MICROARRAY ANALYSIS; MICROARRAY KIT; PRIORITY JOURNAL; TOBACCO DEPENDENCE; AGED; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

ADULT; AGED; EXOME; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-27; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84988883767     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201510-2053OC     Document Type: Article

References (73)

1. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-365.
2. Pillai SG, Ge D, Zhu G, Kong X, Shianna KV, Need AC, Feng S, Hersh CP, Bakke P, Gulsvik A, et al.; ICGN Investigators. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 2009;5:e1000421.
3. Wilk JB, Chen TH, Gottlieb DJ, Walter RE, Nagle MW, Brandler BJ, Myers RH, Borecki IB, Silverman EK, Weiss ST, et al. A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet 2009;5:e1000429.
4. Cho MH, Boutaoui N, Klanderman BJ, Sylvia JS, Ziniti JP, Hersh CP, DeMeo DL, Hunninghake GM, Litonjua AA, Sparrow D, et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet 2010;42:200-202.
5. Cho MH, Castaldi PJ, Wan ES, Siedlinski M, Hersh CP, Demeo DL, Himes BE, Sylvia JS, Klanderman BJ, Ziniti JP, et al.; ICGN Investigators; ECLIPSE Investigators; COPDGene Investigators. A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum Mol Genet 2012;21:947-957.
6. Cho MH, McDonald ML, Zhou X, Mattheisen M, Castaldi PJ, Hersh CP, Demeo DL, Sylvia JS, Ziniti J, Laird NM, et al.; NETT Genetics, ICGN, ECLIPSE and COPDGene Investigators. Risk loci for chronic obstructive pulmonary disease: A genome-wide association study and meta-Analysis. Lancet Respir Med 2014;2:214-225.
7. Zhou JJ, Cho MH, Castaldi PJ, Hersh CP, Silverman EK, Laird NM. Heritability of chronic obstructive pulmonary disease and related phenotypes in smokers. Am J Respir Crit Care Med 2013;188: 941-947.
8. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009;106:9362-9367.
9. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, et al. Finding the missing heritability of complex diseases. Nature 2009;461:747-753.
10. Silverman EK, Sandhaus RA. Alpha1-Antitrypsin deficiency. N Engl J Med 2009;360:2749-2757.
11. Abecasis Lab at the University of Michigan Center for Statistical Genetics. Exome chip design [updated 2013 Aug 6; accessed 2016 Jan 27]. Available from: http://genome.sph.umich.edu/wiki/Exome-Chip-Design
12. Huyghe JR, Jackson AU, Fogarty MP, Buchkovich ML, Stančá ková A, Stringham HM, Sim X, Yang L, Fuchsberger C, Cederberg H, et al. Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion. Nat Genet 2013;45: 197-201.
13. Flannick J, Thorleifsson G, Beer NL, Jacobs SB, Grarup N, Burtt NP, Mahajan A, Fuchsberger C, Atzmon G, Benediktsson R, et al.; Go-T2D Consortium; T2D-GENES Consortium. Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. Nat Genet 2014;46:357-363.
14. Peloso GM, Auer PL, Bis JC, Voorman A, Morrison AC, Stitziel NO, Brody JA, Khetarpal SA, Crosby JR, Fornage M, et al.; NHLBI GO Exome Sequencing Project. Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56, 000 whites and blacks. Am J Hum Genet 2014;94: 223-232.
15. Wessel J, Chu AY, Willems SM, Wang S, Yaghootkar H, Brody JA, Dauriz M, Hivert MF, Raghavan S, Lipovich L, et al.; EPIC-InterAct Consortium. Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility. Nat Commun 2015;6:5897.
16. Hobbs BD, Hardin M, Hawrylkiewicz I, Sliwinski P, Yim JJ, Kim WJ, Kim DK, Agusti A, Make BJ, Calverley PM, et al. Coding variant associations with lung function and COPD using an exome array [abstract]. Am J Respir Crit Care Med 2015;191:A2912.
17. Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 2015;4:7.
18. Purcell S, Chang C. PLINK version 1.9 [accessed 2016 Jan 27]. Available from: https://www.cog-genomics.org/plink2
19. Chen MH, Yang Q. GWAF: genome-wide association/interaction analysis and rare variant analysis with family data. R package version 2.2 [accessed 2016 Jan 27]. Available from: http://CRAN.R-project. org/package=GWAF
20. R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing [accessed 2016 Jan 27]. Available from: http://www.R-project.org/
21. Abecasis G, Li Y, Willer C; Abecasis Lab at the University of Michigan Center for Statistical Genetics. METAL. Version release 2011-03-25 [accessed 2016 Jan 27]. Available from: http://genome.sph.umich. edu/wiki/METAL-Program
22. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-Analysis of genomewide association scans. Bioinformatics 2010;26:2190-2191.
23. Lee S, Miropolsky L, Wu M. SKAT: SNP-set (Sequence) Kernel Association Test. R package version 1.0.1 [accessed 2016 Jan 27]. Available from: http://CRAN.R-project.org/package=SKAT
24. Chen H, Wang C, Conomos MP, Stilp AM, Li Z, Sofer T, Szpiro AA, Chen W, Brehm JM, Celedon JC, et al. Control for population structure and relatedness for binary traits in genetic association studies via logistic mixed models. Am J Hum Genet 2016;98: 653-666.
25. Wu MC, Lee S, Cai T, Li Y, Boehnke M, Lin X. Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet 2011;89:82-93.
26. Lee S. MetaSKAT: Meta-Analysis for SNP-set (Sequence) Kernel Association Test. R package version 0.40 [accessed 2016 Jan 27]. Available from: http://CRAN.R-project.org/package=MetaSKAT
27. Lee S, Emond MJ, Bamshad MJ, Barnes KC, Rieder MJ, Nickerson DA, Christiani DC, Wurfel MM, Lin X; NHLBI GO Exome Sequencing Project-ESP Lung Project Team. Optimal unified approach for rarevariant association testing with application to small-sample casecontrol whole-exome sequencing studies. Am J Hum Genet 2012;91: 224-237.
28. Soler Artigas M, Loth DW, Wain LV, Gharib SA, Obeidat M, Tang W, Zhai G, Zhao JH, Smith AV, Huffman JE, et al.; International Lung Cancer Consortium; GIANT consortium. Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet 2011;43:1082-1090.
29. Hersh CP, DeMeo DL, Silverman EK. Chronic obstructive pulmonary disease. In: Silverman EK, Shapiro SD, Lomas DA, Weiss ST, editors. Respiratory genetics. Boca Raton, FL: CRC Press; 2005. pp. 253-296.
30. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. A method and server for predicting damaging missense mutations. Nat Methods 2010;7:248-249.
31. Kircher M, Witten DM, Jain P, ORoak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 2014;46:310-315.
32. Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, Powell C, Vedantam S, Buchkovich ML, Yang J, et al.; LifeLines Cohort Study; ADIPOGen Consortium; AGEN-BMI Working Group; CARDIOGRAMplusC4D Consortium; CKDGen Consortium; GLGC; ICBP; MAGIC Investigators; MuTHER Consortium; MIGen Consortium; PAGE Consortium; ReproGen Consortium; GENIE Consortium; International Endogene Consortium. Genetic studies of body mass index yield new insights for obesity biology. Nature 2015; 518:197-206.
33. Imielinski M, Baldassano RN, Griffiths A, Russell RK, Annese V, Dubinsky M, Kugathasan S, Bradfield JP, Walters TD, Sleiman P, et al.; Western Regional Alliance for Pediatric IBD; International IBD Genetics Consortium; NIDDK IBD Genetics Consortium; Belgian-French IBD Consortium; Wellcome Trust Case Control Consortium. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet 2009;41: 1335-1340.
34. Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, Lees CW, Balschun T, Lee J, Roberts R, et al. Genome-wide meta-Analysis increases to 71 the number of confirmed Crohns disease susceptibility loci. Nat Genet 2010; 42:1118-1125.
35. Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, Julier C, Morahan G, Nerup J, Nierras C, et al.; Type 1 Diabetes Genetics Consortium. Genome-wide association study and meta-Analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009;41:703-707.
36. Plagnol V, Howson JM, Smyth DJ, Walker N, Hafler JP, Wallace C, Stevens H, Jackson L, Simmonds MJ, Bingley PJ, et al.; Type 1 Diabetes Genetics Consortium. Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet 2011;7:e1002216.
37. Morrow J, Qiu W, DeMeo DL, Houston I, Pinto-Plata VM, Celli BR, Marchetti N, Criner GJ, Bueno R, Washko GR, et al. Network analysis of gene expression in severe COPD lung tissue samples. Am J Respir Crit Care Med 2015;191:A1253.
38. Park SJ, Kleffmann T, Hessian PA. The G82S polymorphism promotes glycosylation of the receptor for advanced glycation end products (RAGE) at asparagine 81: comparison of wild-Type rage with the G82S polymorphic variant. J Biol Chem 2011;286: 21384-21392.
39. Xie J, Reverdatto S, Frolov A, Hoffmann R, Burz DS, Shekhtman A. Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE). J Biol Chem 2008;283: 27255-27269.
40. Spierings E. Minor histocompatibility antigens: past, present, and future. Tissue Antigens 2014;84:374-360.
41. The Broad Institute of MIT and Harvard. GTEx Portal. Version: 4. Build 200 [accessed 2016 Jan 27]. Available from: http://www.gtexportal. org/home/
42. GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat Genet 2013;45:580-585.
43. The human protein atlas [accessed 2016 Jan 27]. Available from: http://www.proteinatlas.org/
44. Uhlé n M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson A , Kampf C, Sjö stedt E, Asplund A, et al. Tissue-based map of the human proteome. Science 2015;347: 1260419.
45. Tobacco and Genetics Consortium. Genome-wide meta-Analyses identify multiple loci associated with smoking behavior. Nat Genet 2010;42:441-447.
46. Castaldi PJ, Cho MH, Zhou X, Qiu W, Mcgeachie M, Celli B, Bakke P, Gulsvik A, Lomas DA, Crapo JD, et al. Genetic control of gene expression at novel and established chronic obstructive pulmonary disease loci. Hum Mol Genet 2015;24:1200-1210.
47. Saccone NL, Culverhouse RC, Schwantes-An TH, Cannon DS, Chen X, Cichon S, Giegling I, Han S, Han Y, Keskitalo-Vuokko K, et al. Multiple independent loci at chromosome 15q25.1 affect smoking quantity: A meta-Analysis and comparison with lung cancer and COPD. PLoS Genet 2010;6: e1001053.
48. Siedlinski M, Tingley D, Lipman PJ, Cho MH, Litonjua AA, Sparrow D, Bakke P, Gulsvik A, Lomas DA, Anderson W, et al.; COPDGene and ECLIPSE Investigators. Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility. Hum Genet 2013;132:431-441.
49. Wilk JB, Shrine NR, Loehr LR, Zhao JH, Manichaikul A, Lopez LM, Smith AV, Heckbert SR, Smolonska J, Tang W, et al. Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. Am J Respir Crit Care Med 2012; 186:622-632.
50. Repapi E, Sayers I, Wain LV, Burton PR, Johnson T, Obeidat M, Zhao JH, Ramasamy A, Zhai G, Vitart V, et al.; Wellcome Trust Case Control Consortium; NSHD Respiratory Study Team. Genome-wide association study identifies five loci associated with lung function. Nat Genet 2010;42:36-44.
51. Hancock DB, Eijgelsheim M, Wilk JB, Gharib SA, Loehr LR, Marciante KD, Franceschini N, van Durme YM, Chen TH, Barr RG, et al. Meta-Analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet 2010; 42:45-52.
52. Burkart KM, Manichaikul A, Wilk JB, Ahmed FS, Burke GL, Enright P, Hansel NN, Haynes D, Heckbert SR, Hoffman EA, et al. APOM and high-density lipoprotein cholesterol are associated with lung function and per cent emphysema. Eur Respir J 2014;43:1003-1017.
53. Cho MH, Castaldi PJ, Hersh CP, Hobbs BD, Barr RG, Tal-Singer R, Bakke P, Gulsvik A, San José Esté par R, Van Beek EJ, et al.; NETT Genetics, ECLIPSE, and COPDGene Investigators. A genome-wide association study of emphysema and airway quantitative imaging phenotypes. Am J Respir Crit Care Med 2015;192:559-569.
54. National Center for Biotechnology Information. dbSNP short genetic variations (dbSNP Build ID: 144). Bethesda, MD: National Library of Medicine [accessed 2016 Jan 27]. Available from: http://www.ncbi. nlm.nih.gov/projects/SNP/
55. Solovieff N, Cotsapas C, Lee PH, Purcell SM, Smoller JW. Pleiotropy in complex traits: challenges and strategies. Nat Rev Genet 2013;14: 483-495.
56. Nú ñez B, Sauleda J, Antó JM, Julia MR, Orozco M, Monsó E, Noguera A, Gómez FP, Garcia-Aymerich J, Agusti A; PAC-COPD Investigators. Anti-Tissue antibodies are related to lung function in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011;183:1025-1031.
57. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009;360: 2445-2454.
58. Hancock DB, Artigas MS, Gharib SA, Henry A, Manichaikul A, Ramasamy A, Loth DW, Imboden M, Koch B, McArdle WL, et al. Genome-wide joint meta-Analysis of SNP and SNP-by-smoking interaction identifies novel loci for pulmonary function. PLoS Genet 2012;8:e1003098.
59. Wang K, Baldassano R, Zhang H, Qu HQ, Imielinski M, Kugathasan S, Annese V, Dubinsky M, Rotter JI, Russell RK, et al. Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. Hum Mol Genet 2010; 19:2059-2067.
60. Jess T, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton LJ III, Munkholm P, Sandborn WJ. Survival and cause specific mortality in patients with inflammatory bowel disease: A long term outcome study in Olmsted County, Minnesota, 1940-2004. Gut 2006;55:1248-1254.
61. Ekbom A, Brandt L, Granath F, Lö fdahl CG, Egesten A. Increased risk of both ulcerative colitis and Crohns disease in a population suffering from COPD. Lung 2008;186:167-172.
62. Yoshida H, Hunter CA. The immunobiology of interleukin-27. Annu Rev Immunol 2015;33:417-443.
63. Huang N, Liu L, Wang XZ, Liu D, Yin SY, Yang XD. Association of interleukin (IL)-12 and IL-27 gene polymorphisms with chronic obstructive pulmonary disease in a Chinese population. DNA Cell Biol 2008;27:527-531.
64. Cao J, Zhang L, Li D, Xu F, Huang S, Xiang Y, Yin Y, Ren G. IL-27 is elevated in patients with COPD and patients with pulmonary TB and induces human bronchial epithelial cells to produce CXCL10. Chest 2012;141:121-130.
65. Angata T, Ishii T, Gao C, Ohtsubo K, Kitazume S, Gemma A, Kida K, Taniguchi N. Association of serum interleukin-27 with the exacerbation of chronic obstructive pulmonary disease. Physiol Rep 2014;2:e12069.
66. McDonald ML, Mattheisen M, Cho MH, Liu YY, Harshfield B, Hersh CP, Bakke P, Gulsvik A, Lange C, Beaty TH, et al.; GenKOLS, COPDGene and ECLIPSE study investigators. Beyond GWAS in COPD: probing the landscape between gene-set associations, genome-wide associations and protein-protein interaction networks. Hum Hered 2014;78:131-139.
67. Gonzá lez JR, Cá ceres A, Esko T, Cuscó I, Puig M, Esnaola M, Reina J, Siroux V, Bouzigon E, Nadif R, et al. A common 16p11.2 inversion underlies the joint susceptibility to asthma and obesity. Am J Hum Genet 2014;94:361-372.
68. Lei Y, Wen H, Yu Y, Taxman DJ, Zhang L, Widman DG, Swanson KV, Wen KW, Damania B, Moore CB, et al. The mitochondrial proteins NLRX1 and TUFM form a complex that regulates type I interferon and autophagy. Immunity 2012;36:933-946.
69. Lei Y, Wen H, Ting JP. The NLR protein, NLRX1, and its partner, TUFM, reduce type I interferon, and enhance autophagy. Autophagy 2013;9: 432-433.
70. Kang MJ, Yoon CM, Kim BH, Lee CM, Zhou Y, Sauler M, Homer R, Dhamija A, Boffa D, West AP, et al. Suppression of NLRX1 in chronic obstructive pulmonary disease. J Clin Invest 2015;125:2458-2462.
71. Han MK, Criner GJ. Update in chronic obstructive pulmonary disease 2012. Am J Respir Crit Care Med 2013;188:29-34.
72. Rennard SI, Vestbo J. The many "small COPDs": COPD should be an orphan disease. Chest 2008;134:623-627.
73. Hersh CP, Make BJ, Lynch DA, Barr RG, Bowler RP, Calverley PM, Castaldi PJ, Cho MH, Coxson HO, DeMeo DL, et al.; COPDGene and ECLIPSE Investigators. Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus. BMC Pulm Med 2014;14:164.